Company Search:
Advanced Search
Sponsored Links
Akebia Therapeutics Inc Company Snapshot
Akebia Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Akebia Therapeutics Inc with three other companies in this sector in the United States: Adverum Biotechnologies Inc (2016 sales of $1.46 million of which 100% was Developing and Commercializing Therapeut), Regulus Therapeutics Incorporated ($1.19 million of which 100% was Pharmaceutical), and Wave Life Sciences Ltd ($1.49 million of which 100% was Pharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Akebia Therapeutics Inc
  Stock Performance Chart for Akebia Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 15.68
(Figures in U.S. Dollars)
1 Week 2.4%   13 Weeks 4.2%  
4 Weeks -15.3%   52 Weeks 57.7%  
Akebia Therapeutics Inc Key Data:
  Ticker: AKBA Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 1,535,000
(Year Ending Jan 2017).
Employees: 90
  Currency: U.S. Dollars Market Cap: 741,180,319
  Fiscal Yr Ends: December Shares Outstanding: 47,269,153
  Share Type: Ordinary Closely Held Shares: 9,303,999
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.